AstraZeneca Pharma India shareholders passed a special resolution to shift the company's registered office from Karnataka to Maharashtra via postal ballot.
The resolution received 100% votes in favor from promoters and 99.99% overall approval from shareholders voting electronically.
The company will amend its Memorandum of Association following the approval and has filed the scrutinizer's report with stock exchanges.
Voting was conducted via remote e-voting from April 12 to May 11, 2026, with results validated by appointed scrutinizer Vijayakrishna KT.